Navigation Links
Vr Laboratories Selects Hsg2001 As Lead Development Candidate For Candida Albicans Program
Date:11/16/2012

Bonita Springs, Fla., Nov. 16, 2012 /PRNewswire-iReach/ -- VR Laboratories LLC today announced they have selected a lead product candidate based on preclinical activity to target Candida albicans (C. albicans). C. albicans is the most common yeast species that causes candidiasis, commonly referred to as yeast infections. Candidiasis includes topical infections such as thrush as well as systemic and potentially life-threatening invasive diseases.

(Photo: http://photos.prnewswire.com/prnh/20121116/CG15396)

Three of every four women experience at least one bout of candidiasis in their lifetime and many experience recurrent infections. Symptoms of candidiasis vary depending on the area of the body that is infected. Candidiasis can be severe and causes more fatalities than any other systemic fungal infection. Candida species are the most common cause of fungal infections in immunocompromised patients such as cancer, AIDS, and transplant patients.

HSG2001 is an orally administered and bioavailable product that prevents the growth of C. albicans in vitro. Preclinical data suggests the product could be used alone or in combination with known antifungals.

"We searched our industry leading natural product library and identified HSG2001 as our lead candidate based on its ability to inhibit C. albicans growth in early stage testing." said Jeff Kottkamp, CEO of VR Laboratories. "We are very excited to expand the utilization of our knowledge and proprietary technology into discovering potential natural medicines for diseases with high unmet medical needs."

About VR Laboratories

VR Laboratories is an innovative natural products company formed by industry professionals in 2010 to be the leading global formulator and producer of natural products.  VR Laboratories utilizes industry-changing proprietary technology to create, produce and market "First in Class" condition specific botanical based consumer health and wellness products, FDA-approved botanical pharmaceuticals and medicines, and proprietary ingredients for medicinal and functional foods and beverages. The company utilizes a proprietary technology platform created by HerbalScience, which has fully developed more than 1,000 medicinal and functional ingredients.  VR Laboratories is headquartered in Bonita Springs, Florida.


'/>"/>
SOURCE VR Laboratories www.vr-laboratories.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
3. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
4. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
5. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
6. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
7. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
8. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
9. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
10. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
11. Carl Icahn Issues Letter To Howard Solomon Of Forest Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , January 17, 2017 ... 1):2-4 ; http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ... ... recently in European Neurological Review ... Catherine Amey reports that despite standard ...
(Date:1/17/2017)... January 17, 2017 Transparency Market Research has ... Acid, Sodium Benzoate, Benzyl Alcohol and Others) Market - Global Industry ... report, the global benzaldehyde derivative market was valued at ... 2.14 Bn by 2024, expanding at a CAGR of 5.1 % ... ...
(Date:1/17/2017)... DUBLIN and BUDAPEST, Hungary , ... ) and Gedeon Richter Plc. today announced positive results from ... trials evaluating the efficacy and safety of ulipristal acetate in ... drug application filing for ulipristal acetate is planned for the ... the favorable results of Venus II supporting the efficacy and ...
Breaking Medicine Technology:
(Date:1/16/2017)... Grove Village, IL (PRWEB) , ... January 16, ... ... and personal audio products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs ... and Convention Center in Las Vegas, Booth #2809. The SHOT Show is the ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s fastest growing ... MD to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, ... a division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, ...
(Date:1/16/2017)... , ... January 16, 2017 , ... St. Louisans are well-aware of the following facts ... This year’s influenza shot seems to be having no effect on keeping this particularly ... half of the people around are coughing, sneezing, or sniffling , These ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all types of ... test for, as well. The money spent screening for and treating cancer in the ... screen patients for cancer more than in any other country that has an advanced ...
(Date:1/15/2017)... , ... January 15, 2017 , ... In this role, ... the United States for the asthma & allergy friendly mark. This certification program was ... test and identify consumer products to be more suitable for the 60+ million people ...
Breaking Medicine News(10 mins):